SlideShare a Scribd company logo
Hormones
General Features
R.C. Gupta
Professor and Head
Department of Biochemistry
National Institute of Medical Sciences
Jaipur, India
Higher animals and human beings possess
a diversity of cells, tissues, organs and
systems for specialized functions
They require mechanisms by which
different cells can communicate with
each other
EMB-RCG
EMB-RCG
Intercellular communication occurs
through:
Nervous system and endocrine system
also communicate with each other
Nervous system Endocrine system
EMB-RCG
Electrical-chemical signals
transmitted through fixed
structural routes
Chemical signals transmitted
in the form of mobile
hormone molecules
Nervous
system
Endocrine
system
EMB-RCG
Systemic effects
Ultimate hormone
↓
Target endocrine gland
↓
↓ Tropic hormone
Anterior pituitary
↓ Releasing hormone
Hypothalamus
↓
External or internal signal
Hormones are present in blood in very
small concentrations yet they produce
profound biological effects
The action of a hormone occurs
through a cascade of events in which the
signal is amplified at a number of stages
EMB-RCG
Amplification
Glucagon-receptor complex
Inactive
adenylate
cyclase
Active
adenylate
cyclase
ATP cAMP
Glycogen Glucose–1–P Glucose
Amplification
Inactive protein
kinase A
Amplification
Amplification
Active phosphorylase
Active protein
kinase A
Inactive phosphorylase
kinase b
Active phosphorylase
kinase b
Inactive phosphorylase
Definition
The target cells may be distant or nearby
The hormone acts on its target cells which
possess specific receptors for the hormone
A molecule secreted by some cells that
controls and regulates the activity of certain
cells or organs
EMB-RCG
Depending on the distance between
the target cell and the hormone-
secreting cell, the hormone may be:
Endocrine hormone
Paracrine hormone
Autocrine hormone
The endocrine hormones are
secreted by endocrine (ductless)
glands, and act on distant cells
The paracrine hormones act on
cells in near vicinity of the
hormone-secreting cells
The autocrine hormones act on the
cells secreting the hormone
EMB-RCG
Hormone receptors
Target cells possess receptors for hormones
Chemically, the receptors are proteins
A receptor is specific for a particular hormone
It has at least two domains, a recognition
domain and a signal domain
The receptor may be located in the cell
membrane or inside the cell
The intracellular receptors may be located
in the cytosol or in the nucleus
A given cell may possess receptors for
several hormones
 Nucleic acids include deoxyribonucleic acid
(DNA) and ribonucleic acid (RNA)
 Both are information molecules
 DNA stores genetic information
 The entire genetic material present in the DNA of
an organism is known as its genome
s
1, 2, 3, 4,
5 and 6
are hormone
receptors
Nucleus Cell membrane
The number of receptors is not fixed
The receptors can undergo:
Up-regulation (increase in
the number of receptors)
Down-regulation (decrease
in the number of receptors)
Classification of hormones
Hormones may be classified
on the basis of:
Chemical nature
Solubility
Location of receptors and
nature of second messengers
EMB-RCG
EMB-RCG
On chemical basis, hormones can
be divided into:
Proteins, peptides
and amino acid
derivatives
Steroids
EMB-RCG
On the basis of solubility, hormones
can be divided into:
Hydrophilic
hormones e.g.
proteins, peptides
and
catecholamines
Hydrophobic
hormones e.g.
steroid hormones
and thyroid
hormones
EMB-RCG
The classification based on the location
of receptors and nature of second
messengers is more comprehensive
On this basis, the hormones may be
divided into two groups:
Group I hormones Group II hormones
Group I hormones
These hormones are lipophilic
Examples are steroid hormones,
thyroid hormones, calcitriol etc
Being lipophilic, they require carrier
proteins to transport them in blood
EMB-RCG
The receptors for glucocorticoids and
mineralocorticoids are present in the
cytosol
The receptors for oestrogen,
progesterone, thyroid hormones and
calcitriol are present in the nucleus
EMB-RCG
Receptors of group I hormones are
intracellular
Being lipid-soluble, the hormones can
easily traverse the cell membrane
Mechanism of action of Group I
hormones
The hormones bind to their intracellular
receptors
The hormone-receptor complex is mobile
It does not require any second
messenger to carry the signal
The receptor possesses:
One domain to recognize and bind
the hormone
Another domain to recognize a
specific sequence in the DNA
The DNA sequence is called
hormone response element (HRE)
There are different response
elements for different hormones like:
Glucocorticoid response
element (GRE)
Mineralocorticoid response
element (MRE)
Thyroid hormone response
element (TRE)
The HREs are located just upstream of
some structural genes and their promoters
The hormone-receptor complex goes to
the nucleus and binds to the HRE
This increases the transcription and
translation of specific genes
The proteins synthesized produce the
biological effects attributed to the hormone
For example, glucocorticoids increase the
expression of genes encoding gluconeogenic
enzymes
Increased synthesis of these enzymes
increases gluconeogenesis
 Nucleic acids include deoxyribonucleic acid
(DNA) and ribonucleic acid (RNA)
 Both are information molecules
 DNA stores genetic information
 The entire genetic material present in the DNA of
an organism is known as its genome
EMB-RCG
Group II hormones
Group II hormones include proteins,
peptides and catecholamines
Being hydrophilic, they do not require
carriers to transport them in blood
Their receptors are trans-membrane
proteins
The second messenger is produced by an
effector
The hormone binds to its receptor on the
cell surface, and does not enter the cell
EMB-RCG
A second messenger is required to carry
the message inside the cell
On hormone-receptor binding, a signal
transducer is activated
The signal transducer goes to, and
activates, an effector
The effector produces a second
messenger
Mechanism of action of Group II
hormones
The second messengers include:
Cyclic AMP (cAMP)
Cyclic GMP (cGMP)
Ca++ and/or phosphoinositides
Tyrosine kinase
EMB-RCG
cAMP
The hormones using cAMP as a second
messenger include:
• TSH
• ACTH
• FSH
• Glucagon
• Epinephrine acting through a2-, b1-
and b2-adrenergic receptors
cAMP is produced in the cell from ATP by
adenylate cyclase, a membrane-bound
enzyme that is normally inactive
Binding of the hormone to its receptor
activates adenylate cyclase
Adenylate cyclase
ATP cAMP + PPi
Concentration of cAMP in the cell
increases
This produces the biological effects
Most of these effects occur due to cAMP-
induced activation of protein kinase A
For example, activation of protein
kinase A in liver by glucagon:
Increases glycogenolysis
Decreases glycogenesis
Adenylate cyclase (effector) is not in
contact with the hormone receptor
The signal is carried from the receptor to
the effector by the signal transducer
(receptor-effector coupling)
The signal transducer is a G-protein
Receptor
G-Protein
G-protein is a trimer made up of an a-
subunit, a b-subunit and a g-subunit
The a-subunit has a site which can be
occupied by GDP or GTP
Normally, it is occupied by GDP
When the hormone binds to its receptor,
GDP is displaced by GTP
Hormone
The GTP-bearing a-subunit dissociates
from the b- and g-subunits
The a-subunit goes and binds to
adenylate cyclase
Adenylate cyclase is activated
Active adenylate cyclase produces cAMP
A.
B.
C.
Hormone
Receptor
GDP
GDP
GTP
G-Protein
Cell membrane
Adenylate cyclase
GTP
ATP cAMP + PPi
a
a-Subunit has intrinsic GTPase activity
which slowly hydrolyses GTP into GDP
When GTP is converted into GDP, the a-
subunit dissociates from the effector
It goes back to and re-associates with the
b- and g-subunits
Pi
GDP
GDP
D.
E.
The G-proteins which stimulate the
effector are known as stimulatory
G-proteins or Gs-proteins
There are inhibitory G-proteins or Gi-
proteins also which inhibit the effector
cGMP
The hormones using cGMP as a second
messenger include:
Atrial natriuretic peptide (ANP)
Nitric oxide (NO) etc
cGMP is formed from GTP by guanylate
cyclase
EMB-RCG
GTP
cGMP
GMP
Guanylate
cyclase
cGMP phospho-
diesterase
PPi
ANP activates the membrane-bound form
NO activates the cytosolic form
Membrane-bound form
Cytosolic (soluble) form
Two forms of guanylate cyclase are
known:
Guanylate cyclase activity is present in the
cytoplasmic portion of the ANP receptor
This is switched on when ANP binds to its
receptor on the cell surface
cGMP is second messenger for NO also
NO is the only hormone known so far
which is a gas
NO is synthesized from arginine by nitric
oxide synthase (NOS)
2 H2N—C—N—CH2—CH2—CH2—CH—COOH
HN H NH2
Arginine
Citrulline
4 O2 + 3 NADPH + 3 H+
2 NO + 3 NADP+ + 4 H2O
Nitric oxide
synthase
II I I
2 H2N—C—N—CH2—CH2—CH2—CH—COOH
II
O H NH2
I I
Guanylate cyclase, activated by ANP and
NO, converts GTP into cGMP
cGMP activates protein kinase G
Protein kinase G phosphorylates some
target proteins
This produces the biological effects
 Nucleic acids include deoxyribonucleic acid
(DNA) and ribonucleic acid (RNA)
 Both are information molecules
 DNA stores genetic information
 The entire genetic material present in the DNA of
an organism is known as its genome
Nitric oxide synthase (NOS) has three
isoforms – iNOS, nNOS and eNOS
iNOS is inducible, and is present in
macrophages and neutrophils
nNOS is present in neurons
eNOS is present in endothelial cells
NO synthesized in phagocytes aids in the
destruction of phagocytosed cells
NO synthesized in neurons acts as a
neurotransmitter
NO formed in endothelial cells diffuses into
adjacent smooth muscles
It causes vasodilatation by relaxing the
smooth muscles
Ca++ and/or phosphoinositides
Hormones using Ca++ and/or phospho-
inositides as second messenger include:
• Oxytocin
• Gastrin
• Cholecystokinin
• Epinephrine acting through a1-adrenergic
receptors
Binding of these hormones to their
receptors activates phosphoinositidase
Phosphoinositidase is a membrane-bound
enzyme
It is also known as phospholipase C
Signal is transmitted from the receptor to
phospholipase C by a G-protein
Activated phospholipase C acts on phos-
phatidyl inositol-4,5-biphosphate (PIP2)
PIP2 is present in the cell membrane
It is formed by phosphorylation of phos-
phatidyl inositol
CH2 — O —C — R1
CH — O — C — R2
CH2 — O —P — O
|
OH
O
||
O
||
O
||
H
H
H
OH
OH OH
H H
OH
H
Phosphatidyl inositol (PI)
OH
CH2— O — C — R1
CH — O — C — R2
CH — O — P — O2
O
||
O
||
O
||
H
H
H
O
OH OH
H H
O
H
Phosphatidyl inositol-4,5-biphosphate (PIP2)
OH
P
|
PI 3-kinase
2 ATP 2 ADP
P
|
|
OH
Phospholipase C hydrolyses phosphatidyl
inositol-4,5-biphosphate (PIP2) into:
Inositol tri-
phosphate (IP3)
Diacylglycerol
(DAG)
CH2 — O —C — R1
CH — O — C — R2
|
CH2 — OH
O
||
O
||
Diacylglycerol
(DAG)
Inositol-1,4,5-triphosphate (IP3)
H
H
O
OH OH
H H
O
HOH
P
|
P
|
O
H
P
|
H2O
Phospholipase C
CH2— O — C — R1
CH — O — C — R2
CH2 — O —P — O
O
||
O
||
O
||
H
H
H
O
OH OH
H H
O
H
Phosphatidyl inositol-4,5-biphosphate (PIP2)
OH
P
|
P
|
|
OH
IP3 releases calcium ions from its intra-
cellular stores e.g. endoplasmic reticulum
Calcium ions combine with calmodulin,
and activate calmodulin kinase
DAG activates protein kinase C
Activated calmodulin kinase and protein
kinase C cause phosphorylation of some
target proteins
The phosphorylated proteins produce
the biological effects
Hormone
Receptor
Phosphatidyl inositol-4, 5-biphosphate
Endoplasmic
reticulum
Inositol
triphosphate
Diacylglycerol
Calmodulin
Ca++–Calmodulin
Calmodulin kinase Protein kinase C
Phosphorylation of target proteins
Biological effects
+
Ca++
+
+
Phospholipase C
G-
Protein
The hormones acting via tyrosine kinase
include insulin, growth hormone, prolactin
etc
These hormones act by phosphorylating
tyrosine residues of some target proteins
in the cell
Tyrosine kinase
EMB-RCG
Most of the growth factors also act by
tyrosine phosphorylation, for example:
Insulin-like growth factor-1 (IGF-1)
Insulin-like growth factor-2 (IGF-2)
Nerve growth factor (NGF)
Epidermal growth factor (EGF)
Platelet-derived growth factor (PDGF)
Receptors for hormones acting via tyrosine
kinase are trans-membrane
The extracellular portion of the receptor has
got the hormone-binding domain
The cytoplasmic portion has got tyrosine
kinase domain
When the hormone binds to the receptor,
tyrosine kinase domain becomes active
Tyrosine kinase phosphorylates some
tyrosine residues in the receptor itself
The receptor becomes auto-phosphorylated
The auto-phosphorylated receptor
phosphorylates the tyrosine residues of
some target proteins
The target proteins become active and
produce the biological effects
An example of this subgroup of hormones
is insulin
Insulin receptor is made of two a-chains
and two b-chains
The a-chains are linked to each other by
disulphide bonds
The a-chains are linked to b-chains by
disulphide bonds
The a-chains are entirely extracellular
The b-chains are partly extracellular, partly
membrane-embedded and partly cytosolic
The a-chains possess the insulin-binding
site
The cytoplasmic portion of b-chains
possesses tyrosine kinase domain
The tyrosine kinase domain is normally
inactive
HOOC‒
H2N
I
NH2
I
‒COOH
H2N‒ ‒NH2
I
HOOC
I
COOH
I
S
I
S
I
I
S
I
S
I
‒S‒S‒
‒‒ Tyrosine kinase domain
a-Chain ‒‒
b-Chain ‒‒
Cell
membrane ‒
Insulin receptor
Binding of insulin to the a-chains switches
on the tyrosine kinase activity of b-chains
Active tyrosine kinase phosphorylates
some tyrosine residues in the b-chains
The receptor becomes auto-phosphorylated
Autophosphorylated insulin receptor
I
S
I
S
I
I
S
I
S
I
‒S‒S‒
Insulin
P P
P P
The auto-phosphorylated receptor phospho-
rylates tyrosine residues of some target
proteins
These include insulin receptor substrate-1
(IRS-1), insulin receptor substrate-2 (IRS-2)
etc
This initiates a cascade of reactions
culminating in the varied biological effects of
insulin
Minute amounts of hormones produce
profound biological effects
Therefore, regulation of hormone secretion
should be very precise
Hormone secretion should increase when
its biological effect is required
It should decrease when the desired
biological effect has been achieved
Regulation of hormone secretion
Hypothalamo-hypophyseal-endocrine axis
is one regulatory cascade
It is involved in the regulation of several
hormones
Feedback inhibition is another important
mechanism
A rise in hormone concentration causes
feedback inhibition of hormone secretion
As an example, secretion of thyroid hormones
is regulated by both the mechanisms
When there is need for thyroid hormones,
hypothalamus secretes thyrotropin-releasing
hormone (TRH)
TRH stimulates anterior pituitary to secrete
thyroid stimulating hormone (TSH)
TSH acts on thyroid gland and stimulates
the secretion of thyroid hormones
Raised blood level of thyroid hormones
causes feedback inhibition of:
TRH secretion
TSH secretion
Secretion of thyroid hormones
Hypothalamus
Anterior pituitary
Thyroid gland
Thyrotropin-releasing hormone
Thyroid-stimulating hormone
Thyroxine and
tri-iodothyronine
+
+
–
–
–
In some cases, feedback regulation is
exercised by some metabolite affected by
the hormone
An example is regulation of
parathormone (PTH) secretion
A decrease in plasma calcium
concentration evokes PTH secretion
PTH initiates a series of reactions leading
to a rise in plasma calcium concentration
Rise in plasma calcium level causes
feedback inhibition of PTH secretion
Plasma calcium
Parathyroid glands
Parathrormone Θ
Hormones are present in blood in very
minute concentrations
Usual techniques are not suitable for
measuring hormone concentrations
Yet measurements are often required for
diagnosis of endocrine disorders
Assay of hormone concentrations
In the past, hormone concentrations were
measured by bio-assay
Biological effect of the hormone was
measured in live animals or in tissues
This lacked sensitivity
Modern techniques are generally based
on antigen-antibody reaction
These immunochemical techniques are
quick, accurate and sensitive
The common immuno-
chemical techniques are:
Radio-immuno-assay
Enzyme-immuno-assay
Chemiluminescence-immuno-assay
Antibodies are prepared against the
hormone
The hormone is labeled with a radio-
active isotope e.g. 125I
Labeled hormone, unlabeled hormone and
the antibody are added to a test tube
Radio-immuno-assay (RIA)
The amount of antibody is kept very low
Labeled and unlabeled hormone compete
with each other to bind to the antibody
The degree of binding depends upon their
relative concentrations
The amount of antibody bound to labeled
hormone is quantitated by measuring
radio-activity
Radio-activity emitted by 125I can be
measured by a gamma counter
Briefly, the steps are:
A series of tubes, marked S1, S2, S3, S4 etc
(standards) and U (unknown), is set up
A fixed, and relatively small, amount of
antibody (Ab) is added to each tube
A fixed amount of labeled hormone (Ag*)
is added to each tube
EMB-RCG
Unlabeled hormone (Ag) is added to
tubes marked S1, S2, S3 , S4 etc in
increasing amounts (C1, C2, C3 , C4 etc)
Patient’s serum having an unknown
amount of unlabeled hormone (CU) is
added to the tube marked U
EMB-RCG
Amount of antibody
(Ab) x x x x x
Amount of labeled
hormone (Ag*) y y y y y
Amount of unlabeled
hormone (Ag) C1 C2 C3 C4 ‒
Amount of hormone
in patient’s serum – – – – CU
S1 S2 S3 S4 U
The tubes are incubated for a fixed period
Some Ab combines with Ag and some
with Ag*
EMB-RCG
Ag and Ag* compete with each other
to bind to the limited amount of Ab
The tubes are centrifuged
EMB-RCG
Ag-Ab and Ag*-Ab complexes settle at
the bottom
Amounts of Ag-Ab and Ag*-Ab complex in a
tube depend upon amounts of Ag* and Ag
If the amount of Ag is less than that of Ag*,
less Ag-Ab complex will be formed than
Ag*-Ab complex
As the amount of Ag increases, more Ag-Ab
and less Ag*-Ab complex will be formed
Ag*-Ab complex is radio-active while
Ag-Ab complex is not
The concentration of Ag*-Ab complex in
different tubes will be different
Its concentration will be inversely
proportional to the concentration of Ag
Ag + Ag* + Ab → Ag-Ab + Ag*-Ab + Ag* + Ag
The supernatant containing unbound Ag
and Ag* is removed
Since antibody concentration is low,
some unbound Ag and Ag* will also
remain in each tube
Radioactivity is measured in each tube
A calibration curve is prepared by plotting
radioactivity in S1, S2, S3 etc against the
concentrations of Ag (C1, C2, C3 etc)
The concentration of hormone in the
patient’s serum (CU) can be read off from
the calibration curve
Hormone concentration →
C1 C2
Cu
C3 C4
↑
Radio-
activity
Calibration curve
The principle of EIA is similar to that of RIA
Instead of an isotope, an enzyme is used
as a label
The common enzymes used as label are
peroxidase and alkaline phosphatase
Enzyme-immuno-assay (EIA)
Instead of measuring radioactivity, the
enzyme concentration is measured
For measuring enzyme concentration,
substrate of the enzyme is added
The amount of product formed is
determined after a fixed interval
A common form of EIA is enzyme-linked
immuno-sorbent assay (ELISA)
In ELISA, the antibody is fixed on a solid
support
The solid support may be wells molded in
a plastic plate
An ELISA plate with wells molded in it
Antibody concentration in the wells is
much higher than antigen (hormone)
concentration
The wells are labeled S1, S2, S3, S4 etc for
standard solutions
The well labeled U is for unknown i.e.
patient’s serum
The steps are:
Standard hormone solutions in increasing
concentrations (C1, C2, C3 etc) are added
to the wells marked S1, S2, S3 etc
Patient’s serum having an unknown
hormone concentration (CU) is added
to the well U
Hormone molecules bind to the fixed
antibody molecules
EMB-RCG
A second antibody recognizing a different
epitope of the antigen (hormone) is tagged
with an enzyme
It is added to each well in a relatively large
amount
The enzyme-linked antibody also binds to
the hormone
EMB-RCG
One
epitope
│
│
One
antibody
│
Second
antibody
Enzyme
│
ANTIGEN
Second
epitope
│
Complex
The unbound enzyme-linked antibody
molecules are washed off
Each well now contains complexes of the
fixed antibody, the antigen and the
enzyme-linked antibody
EMB-RCG
A fixed amount of substrate of the
enzyme is added to each well
The enzyme converts the substrate
into a coloured product
EMB-RCG
Substrate → Product
Antibody fixed in
well
Antigen added;
binds to antibody
Enzyme-linked
antibody added;
binds to antigen
Substrate added;
converted into
product



The absorbance is proportional to the
enzyme concentration
The enzyme concentration is proportional to
the hormone concentration
EMB-RCG
After a fixed incubation period, intensity of
colour (absorbance) is measured in each
well
A calibration curve is plotted between
the known concentrations of hormone
(C1, C2, C3 etc) and the absorbance
The hormone concentration in the
patient’s serum (CU) can be read off
from the calibration curve
EMB-RCG
Hormone concentration →
C1 C2 C3 C4
CU
↑
Absorbance
Calibration curve
CLIA is based on chemiluminescence i.e.
emission of light driven by a chemical
reaction
Principle of CLIA is similar to that of EIA
Instead of an enzyme, a chemiluminescent
substance is used as a label
Chemiluminescence-immuno-assay (CLIA)
Chemiluminescent
substances include:
Luminol
Isoluminol
Acridium esters
The resulting emission of light is measured
The chemiluminescent substance is
usually oxidised to form an excited
intermediate
When this intermediate returns to the
ground state, it releases photons
Luminol + H2O2
↓
3-Aminophthalate + H2O + Light
Peroxidase
The reaction will occur on addition of H2O2
Luminol can be used as a label
Luminol and peroxidase
before adding H2O2
Chemiluminescence
after addition of H2O2
Chemiluminescence is measured by a luminometer
CLIA is extremely sensitive, quick and
relatively economical
It is linear over a wide range of
concentrations of the analyte
Shelf-life of CLIA reagents is fairly long

More Related Content

What's hot

Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.ppt
Dr. Khuram Aziz
 

What's hot (20)

Metabolism of Glycine. .
Metabolism of Glycine. .Metabolism of Glycine. .
Metabolism of Glycine. .
 
Gluconeogenesis
Gluconeogenesis Gluconeogenesis
Gluconeogenesis
 
Eicosanoid synthesis
Eicosanoid synthesisEicosanoid synthesis
Eicosanoid synthesis
 
G Proteins
G ProteinsG Proteins
G Proteins
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
Steroid Hormones
Steroid HormonesSteroid Hormones
Steroid Hormones
 
hormones: mechanism amd action 2
hormones: mechanism amd action 2hormones: mechanism amd action 2
hormones: mechanism amd action 2
 
BIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDESBIOSYNTHESIS OF PURINE NUCLEOTIDES
BIOSYNTHESIS OF PURINE NUCLEOTIDES
 
Mechanism of action of hormones
Mechanism of action of hormonesMechanism of action of hormones
Mechanism of action of hormones
 
TRANSAMINATION & DEAMINATION
TRANSAMINATION & DEAMINATIONTRANSAMINATION & DEAMINATION
TRANSAMINATION & DEAMINATION
 
Mechanism of Hormone Action
Mechanism of Hormone ActionMechanism of Hormone Action
Mechanism of Hormone Action
 
GLYCINE METABOLISM
GLYCINE METABOLISMGLYCINE METABOLISM
GLYCINE METABOLISM
 
Amino acid metabolism | Transamination | Deamination |
Amino acid metabolism | Transamination | Deamination |Amino acid metabolism | Transamination | Deamination |
Amino acid metabolism | Transamination | Deamination |
 
Regulation of glycogen metabolism
Regulation of glycogen metabolismRegulation of glycogen metabolism
Regulation of glycogen metabolism
 
Glycoproteins
Glycoproteins Glycoproteins
Glycoproteins
 
Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.ppt
 
Metabolism of glycogen
Metabolism of glycogenMetabolism of glycogen
Metabolism of glycogen
 
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISMGLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
 
GLYCOGENESIS
GLYCOGENESISGLYCOGENESIS
GLYCOGENESIS
 
Regulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesisRegulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesis
 

Similar to Hormones - general features

G protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeuticsG protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeutics
priyanka527
 
Signalling mechanism of hormones and neuroendocrine
Signalling mechanism of hormones and neuroendocrineSignalling mechanism of hormones and neuroendocrine
Signalling mechanism of hormones and neuroendocrine
Burhan Umer
 

Similar to Hormones - general features (20)

Hormone (1).pptx
Hormone (1).pptxHormone (1).pptx
Hormone (1).pptx
 
Second Messenger Systems
Second Messenger SystemsSecond Messenger Systems
Second Messenger Systems
 
G protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeuticsG protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeutics
 
Mechanisms of action of hormones and signaling molecules
Mechanisms of action of hormones  and signaling moleculesMechanisms of action of hormones  and signaling molecules
Mechanisms of action of hormones and signaling molecules
 
Hormones
HormonesHormones
Hormones
 
hormone final.pptx
hormone final.pptxhormone final.pptx
hormone final.pptx
 
Signal transduction
Signal transductionSignal transduction
Signal transduction
 
SIGNAL TRANSDUCTION.pptx
SIGNAL TRANSDUCTION.pptxSIGNAL TRANSDUCTION.pptx
SIGNAL TRANSDUCTION.pptx
 
G protien coupled receptor by yatendra singh
G  protien coupled receptor by yatendra singhG  protien coupled receptor by yatendra singh
G protien coupled receptor by yatendra singh
 
Unit 1 receptors as drug target
Unit  1 receptors as drug target Unit  1 receptors as drug target
Unit 1 receptors as drug target
 
SIGNAL TRANSDUCTION (1).pptx
SIGNAL TRANSDUCTION (1).pptxSIGNAL TRANSDUCTION (1).pptx
SIGNAL TRANSDUCTION (1).pptx
 
Receptor
ReceptorReceptor
Receptor
 
Signalling mechanism of hormones and neuroendocrine
Signalling mechanism of hormones and neuroendocrineSignalling mechanism of hormones and neuroendocrine
Signalling mechanism of hormones and neuroendocrine
 
Second messengers and classification of hormone
Second messengers and  classification of hormoneSecond messengers and  classification of hormone
Second messengers and classification of hormone
 
Biochemistry of hormones
Biochemistry of hormonesBiochemistry of hormones
Biochemistry of hormones
 
Hormonal control in transcription
Hormonal control in transcriptionHormonal control in transcription
Hormonal control in transcription
 
Receptors-1
Receptors-1Receptors-1
Receptors-1
 
Receptors 1
Receptors 1Receptors 1
Receptors 1
 
Gpcr signalling
Gpcr signallingGpcr signalling
Gpcr signalling
 
Signal transduction presentation
Signal transduction presentationSignal transduction presentation
Signal transduction presentation
 

More from Ramesh Gupta

More from Ramesh Gupta (20)

Ethical issues in research.pptx
Ethical issues in research.pptxEthical issues in research.pptx
Ethical issues in research.pptx
 
Writing a research paper.pptx
Writing a research paper.pptxWriting a research paper.pptx
Writing a research paper.pptx
 
Research - An Overview.pptx
Research - An Overview.pptxResearch - An Overview.pptx
Research - An Overview.pptx
 
MCQs on Chemistry of Lipids
MCQs on Chemistry of LipidsMCQs on Chemistry of Lipids
MCQs on Chemistry of Lipids
 
MCQs on Chemistry of Carbohydrates
MCQs on Chemistry of CarbohydratesMCQs on Chemistry of Carbohydrates
MCQs on Chemistry of Carbohydrates
 
Cell mediated immunity
Cell mediated immunityCell mediated immunity
Cell mediated immunity
 
Humoral immunity
Humoral immunityHumoral immunity
Humoral immunity
 
Indian medical graduate - goals, roles and competencies
Indian medical graduate -  goals, roles and competenciesIndian medical graduate -  goals, roles and competencies
Indian medical graduate - goals, roles and competencies
 
Educational networking
Educational networkingEducational networking
Educational networking
 
Acid base balance - Regulation of pH of body fluids
Acid base balance - Regulation of pH of body fluidsAcid base balance - Regulation of pH of body fluids
Acid base balance - Regulation of pH of body fluids
 
Enzymes - The biological catalysts
Enzymes - The biological catalystsEnzymes - The biological catalysts
Enzymes - The biological catalysts
 
Chemistry of amino acids
Chemistry of amino acidsChemistry of amino acids
Chemistry of amino acids
 
Metabolism of nucleotides
Metabolism of nucleotidesMetabolism of nucleotides
Metabolism of nucleotides
 
Biochemistry an overview
Biochemistry   an overviewBiochemistry   an overview
Biochemistry an overview
 
Cell cycle and apoptosis
Cell cycle and apoptosisCell cycle and apoptosis
Cell cycle and apoptosis
 
Cancer and genes
Cancer and genesCancer and genes
Cancer and genes
 
Recombinant dna technology applications
Recombinant dna technology   applicationsRecombinant dna technology   applications
Recombinant dna technology applications
 
Recombinant dna technology tools and techniques
Recombinant dna technology   tools and techniquesRecombinant dna technology   tools and techniques
Recombinant dna technology tools and techniques
 
Rna interference
Rna interferenceRna interference
Rna interference
 
Protein synthesis
Protein synthesisProtein synthesis
Protein synthesis
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 

Hormones - general features

  • 1. Hormones General Features R.C. Gupta Professor and Head Department of Biochemistry National Institute of Medical Sciences Jaipur, India
  • 2. Higher animals and human beings possess a diversity of cells, tissues, organs and systems for specialized functions They require mechanisms by which different cells can communicate with each other EMB-RCG
  • 3. EMB-RCG Intercellular communication occurs through: Nervous system and endocrine system also communicate with each other Nervous system Endocrine system
  • 4. EMB-RCG Electrical-chemical signals transmitted through fixed structural routes Chemical signals transmitted in the form of mobile hormone molecules Nervous system Endocrine system
  • 5. EMB-RCG Systemic effects Ultimate hormone ↓ Target endocrine gland ↓ ↓ Tropic hormone Anterior pituitary ↓ Releasing hormone Hypothalamus ↓ External or internal signal
  • 6. Hormones are present in blood in very small concentrations yet they produce profound biological effects The action of a hormone occurs through a cascade of events in which the signal is amplified at a number of stages EMB-RCG
  • 7. Amplification Glucagon-receptor complex Inactive adenylate cyclase Active adenylate cyclase ATP cAMP Glycogen Glucose–1–P Glucose Amplification Inactive protein kinase A Amplification Amplification Active phosphorylase Active protein kinase A Inactive phosphorylase kinase b Active phosphorylase kinase b Inactive phosphorylase
  • 8. Definition The target cells may be distant or nearby The hormone acts on its target cells which possess specific receptors for the hormone A molecule secreted by some cells that controls and regulates the activity of certain cells or organs
  • 9. EMB-RCG Depending on the distance between the target cell and the hormone- secreting cell, the hormone may be: Endocrine hormone Paracrine hormone Autocrine hormone
  • 10. The endocrine hormones are secreted by endocrine (ductless) glands, and act on distant cells The paracrine hormones act on cells in near vicinity of the hormone-secreting cells The autocrine hormones act on the cells secreting the hormone EMB-RCG
  • 11. Hormone receptors Target cells possess receptors for hormones Chemically, the receptors are proteins A receptor is specific for a particular hormone It has at least two domains, a recognition domain and a signal domain
  • 12. The receptor may be located in the cell membrane or inside the cell The intracellular receptors may be located in the cytosol or in the nucleus A given cell may possess receptors for several hormones
  • 13.  Nucleic acids include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA)  Both are information molecules  DNA stores genetic information  The entire genetic material present in the DNA of an organism is known as its genome s 1, 2, 3, 4, 5 and 6 are hormone receptors Nucleus Cell membrane
  • 14. The number of receptors is not fixed The receptors can undergo: Up-regulation (increase in the number of receptors) Down-regulation (decrease in the number of receptors)
  • 15. Classification of hormones Hormones may be classified on the basis of: Chemical nature Solubility Location of receptors and nature of second messengers EMB-RCG
  • 16. EMB-RCG On chemical basis, hormones can be divided into: Proteins, peptides and amino acid derivatives Steroids
  • 17. EMB-RCG On the basis of solubility, hormones can be divided into: Hydrophilic hormones e.g. proteins, peptides and catecholamines Hydrophobic hormones e.g. steroid hormones and thyroid hormones
  • 18. EMB-RCG The classification based on the location of receptors and nature of second messengers is more comprehensive On this basis, the hormones may be divided into two groups: Group I hormones Group II hormones
  • 19. Group I hormones These hormones are lipophilic Examples are steroid hormones, thyroid hormones, calcitriol etc Being lipophilic, they require carrier proteins to transport them in blood EMB-RCG
  • 20. The receptors for glucocorticoids and mineralocorticoids are present in the cytosol The receptors for oestrogen, progesterone, thyroid hormones and calcitriol are present in the nucleus EMB-RCG
  • 21. Receptors of group I hormones are intracellular Being lipid-soluble, the hormones can easily traverse the cell membrane Mechanism of action of Group I hormones
  • 22. The hormones bind to their intracellular receptors The hormone-receptor complex is mobile It does not require any second messenger to carry the signal
  • 23. The receptor possesses: One domain to recognize and bind the hormone Another domain to recognize a specific sequence in the DNA The DNA sequence is called hormone response element (HRE)
  • 24. There are different response elements for different hormones like: Glucocorticoid response element (GRE) Mineralocorticoid response element (MRE) Thyroid hormone response element (TRE)
  • 25. The HREs are located just upstream of some structural genes and their promoters The hormone-receptor complex goes to the nucleus and binds to the HRE This increases the transcription and translation of specific genes
  • 26. The proteins synthesized produce the biological effects attributed to the hormone For example, glucocorticoids increase the expression of genes encoding gluconeogenic enzymes Increased synthesis of these enzymes increases gluconeogenesis
  • 27.  Nucleic acids include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA)  Both are information molecules  DNA stores genetic information  The entire genetic material present in the DNA of an organism is known as its genome EMB-RCG
  • 28. Group II hormones Group II hormones include proteins, peptides and catecholamines Being hydrophilic, they do not require carriers to transport them in blood Their receptors are trans-membrane proteins
  • 29. The second messenger is produced by an effector The hormone binds to its receptor on the cell surface, and does not enter the cell EMB-RCG A second messenger is required to carry the message inside the cell
  • 30. On hormone-receptor binding, a signal transducer is activated The signal transducer goes to, and activates, an effector The effector produces a second messenger Mechanism of action of Group II hormones
  • 31. The second messengers include: Cyclic AMP (cAMP) Cyclic GMP (cGMP) Ca++ and/or phosphoinositides Tyrosine kinase EMB-RCG
  • 32. cAMP The hormones using cAMP as a second messenger include: • TSH • ACTH • FSH • Glucagon • Epinephrine acting through a2-, b1- and b2-adrenergic receptors
  • 33. cAMP is produced in the cell from ATP by adenylate cyclase, a membrane-bound enzyme that is normally inactive Binding of the hormone to its receptor activates adenylate cyclase Adenylate cyclase ATP cAMP + PPi
  • 34. Concentration of cAMP in the cell increases This produces the biological effects Most of these effects occur due to cAMP- induced activation of protein kinase A
  • 35. For example, activation of protein kinase A in liver by glucagon: Increases glycogenolysis Decreases glycogenesis
  • 36. Adenylate cyclase (effector) is not in contact with the hormone receptor The signal is carried from the receptor to the effector by the signal transducer (receptor-effector coupling) The signal transducer is a G-protein
  • 38. G-protein is a trimer made up of an a- subunit, a b-subunit and a g-subunit The a-subunit has a site which can be occupied by GDP or GTP Normally, it is occupied by GDP When the hormone binds to its receptor, GDP is displaced by GTP
  • 40. The GTP-bearing a-subunit dissociates from the b- and g-subunits The a-subunit goes and binds to adenylate cyclase Adenylate cyclase is activated Active adenylate cyclase produces cAMP
  • 42. a-Subunit has intrinsic GTPase activity which slowly hydrolyses GTP into GDP When GTP is converted into GDP, the a- subunit dissociates from the effector It goes back to and re-associates with the b- and g-subunits
  • 44. The G-proteins which stimulate the effector are known as stimulatory G-proteins or Gs-proteins There are inhibitory G-proteins or Gi- proteins also which inhibit the effector
  • 45. cGMP The hormones using cGMP as a second messenger include: Atrial natriuretic peptide (ANP) Nitric oxide (NO) etc cGMP is formed from GTP by guanylate cyclase
  • 47. ANP activates the membrane-bound form NO activates the cytosolic form Membrane-bound form Cytosolic (soluble) form Two forms of guanylate cyclase are known:
  • 48. Guanylate cyclase activity is present in the cytoplasmic portion of the ANP receptor This is switched on when ANP binds to its receptor on the cell surface
  • 49. cGMP is second messenger for NO also NO is the only hormone known so far which is a gas NO is synthesized from arginine by nitric oxide synthase (NOS)
  • 50. 2 H2N—C—N—CH2—CH2—CH2—CH—COOH HN H NH2 Arginine Citrulline 4 O2 + 3 NADPH + 3 H+ 2 NO + 3 NADP+ + 4 H2O Nitric oxide synthase II I I 2 H2N—C—N—CH2—CH2—CH2—CH—COOH II O H NH2 I I
  • 51. Guanylate cyclase, activated by ANP and NO, converts GTP into cGMP cGMP activates protein kinase G Protein kinase G phosphorylates some target proteins This produces the biological effects
  • 52.  Nucleic acids include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA)  Both are information molecules  DNA stores genetic information  The entire genetic material present in the DNA of an organism is known as its genome
  • 53. Nitric oxide synthase (NOS) has three isoforms – iNOS, nNOS and eNOS iNOS is inducible, and is present in macrophages and neutrophils nNOS is present in neurons eNOS is present in endothelial cells
  • 54. NO synthesized in phagocytes aids in the destruction of phagocytosed cells NO synthesized in neurons acts as a neurotransmitter NO formed in endothelial cells diffuses into adjacent smooth muscles It causes vasodilatation by relaxing the smooth muscles
  • 55. Ca++ and/or phosphoinositides Hormones using Ca++ and/or phospho- inositides as second messenger include: • Oxytocin • Gastrin • Cholecystokinin • Epinephrine acting through a1-adrenergic receptors Binding of these hormones to their receptors activates phosphoinositidase
  • 56. Phosphoinositidase is a membrane-bound enzyme It is also known as phospholipase C Signal is transmitted from the receptor to phospholipase C by a G-protein
  • 57. Activated phospholipase C acts on phos- phatidyl inositol-4,5-biphosphate (PIP2) PIP2 is present in the cell membrane It is formed by phosphorylation of phos- phatidyl inositol
  • 58. CH2 — O —C — R1 CH — O — C — R2 CH2 — O —P — O | OH O || O || O || H H H OH OH OH H H OH H Phosphatidyl inositol (PI) OH CH2— O — C — R1 CH — O — C — R2 CH — O — P — O2 O || O || O || H H H O OH OH H H O H Phosphatidyl inositol-4,5-biphosphate (PIP2) OH P | PI 3-kinase 2 ATP 2 ADP P | | OH
  • 59. Phospholipase C hydrolyses phosphatidyl inositol-4,5-biphosphate (PIP2) into: Inositol tri- phosphate (IP3) Diacylglycerol (DAG)
  • 60. CH2 — O —C — R1 CH — O — C — R2 | CH2 — OH O || O || Diacylglycerol (DAG) Inositol-1,4,5-triphosphate (IP3) H H O OH OH H H O HOH P | P | O H P | H2O Phospholipase C CH2— O — C — R1 CH — O — C — R2 CH2 — O —P — O O || O || O || H H H O OH OH H H O H Phosphatidyl inositol-4,5-biphosphate (PIP2) OH P | P | | OH
  • 61. IP3 releases calcium ions from its intra- cellular stores e.g. endoplasmic reticulum Calcium ions combine with calmodulin, and activate calmodulin kinase DAG activates protein kinase C
  • 62. Activated calmodulin kinase and protein kinase C cause phosphorylation of some target proteins The phosphorylated proteins produce the biological effects
  • 63. Hormone Receptor Phosphatidyl inositol-4, 5-biphosphate Endoplasmic reticulum Inositol triphosphate Diacylglycerol Calmodulin Ca++–Calmodulin Calmodulin kinase Protein kinase C Phosphorylation of target proteins Biological effects + Ca++ + + Phospholipase C G- Protein
  • 64. The hormones acting via tyrosine kinase include insulin, growth hormone, prolactin etc These hormones act by phosphorylating tyrosine residues of some target proteins in the cell Tyrosine kinase
  • 65. EMB-RCG Most of the growth factors also act by tyrosine phosphorylation, for example: Insulin-like growth factor-1 (IGF-1) Insulin-like growth factor-2 (IGF-2) Nerve growth factor (NGF) Epidermal growth factor (EGF) Platelet-derived growth factor (PDGF)
  • 66. Receptors for hormones acting via tyrosine kinase are trans-membrane The extracellular portion of the receptor has got the hormone-binding domain The cytoplasmic portion has got tyrosine kinase domain
  • 67. When the hormone binds to the receptor, tyrosine kinase domain becomes active Tyrosine kinase phosphorylates some tyrosine residues in the receptor itself The receptor becomes auto-phosphorylated
  • 68. The auto-phosphorylated receptor phosphorylates the tyrosine residues of some target proteins The target proteins become active and produce the biological effects
  • 69. An example of this subgroup of hormones is insulin Insulin receptor is made of two a-chains and two b-chains The a-chains are linked to each other by disulphide bonds
  • 70. The a-chains are linked to b-chains by disulphide bonds The a-chains are entirely extracellular The b-chains are partly extracellular, partly membrane-embedded and partly cytosolic
  • 71. The a-chains possess the insulin-binding site The cytoplasmic portion of b-chains possesses tyrosine kinase domain The tyrosine kinase domain is normally inactive
  • 72. HOOC‒ H2N I NH2 I ‒COOH H2N‒ ‒NH2 I HOOC I COOH I S I S I I S I S I ‒S‒S‒ ‒‒ Tyrosine kinase domain a-Chain ‒‒ b-Chain ‒‒ Cell membrane ‒ Insulin receptor
  • 73. Binding of insulin to the a-chains switches on the tyrosine kinase activity of b-chains Active tyrosine kinase phosphorylates some tyrosine residues in the b-chains The receptor becomes auto-phosphorylated
  • 75. The auto-phosphorylated receptor phospho- rylates tyrosine residues of some target proteins These include insulin receptor substrate-1 (IRS-1), insulin receptor substrate-2 (IRS-2) etc This initiates a cascade of reactions culminating in the varied biological effects of insulin
  • 76. Minute amounts of hormones produce profound biological effects Therefore, regulation of hormone secretion should be very precise Hormone secretion should increase when its biological effect is required It should decrease when the desired biological effect has been achieved Regulation of hormone secretion
  • 77. Hypothalamo-hypophyseal-endocrine axis is one regulatory cascade It is involved in the regulation of several hormones Feedback inhibition is another important mechanism A rise in hormone concentration causes feedback inhibition of hormone secretion
  • 78. As an example, secretion of thyroid hormones is regulated by both the mechanisms When there is need for thyroid hormones, hypothalamus secretes thyrotropin-releasing hormone (TRH) TRH stimulates anterior pituitary to secrete thyroid stimulating hormone (TSH)
  • 79. TSH acts on thyroid gland and stimulates the secretion of thyroid hormones Raised blood level of thyroid hormones causes feedback inhibition of: TRH secretion TSH secretion Secretion of thyroid hormones
  • 80. Hypothalamus Anterior pituitary Thyroid gland Thyrotropin-releasing hormone Thyroid-stimulating hormone Thyroxine and tri-iodothyronine + + – – –
  • 81. In some cases, feedback regulation is exercised by some metabolite affected by the hormone An example is regulation of parathormone (PTH) secretion A decrease in plasma calcium concentration evokes PTH secretion
  • 82. PTH initiates a series of reactions leading to a rise in plasma calcium concentration Rise in plasma calcium level causes feedback inhibition of PTH secretion
  • 84. Hormones are present in blood in very minute concentrations Usual techniques are not suitable for measuring hormone concentrations Yet measurements are often required for diagnosis of endocrine disorders Assay of hormone concentrations
  • 85. In the past, hormone concentrations were measured by bio-assay Biological effect of the hormone was measured in live animals or in tissues This lacked sensitivity
  • 86. Modern techniques are generally based on antigen-antibody reaction These immunochemical techniques are quick, accurate and sensitive
  • 87. The common immuno- chemical techniques are: Radio-immuno-assay Enzyme-immuno-assay Chemiluminescence-immuno-assay
  • 88. Antibodies are prepared against the hormone The hormone is labeled with a radio- active isotope e.g. 125I Labeled hormone, unlabeled hormone and the antibody are added to a test tube Radio-immuno-assay (RIA)
  • 89. The amount of antibody is kept very low Labeled and unlabeled hormone compete with each other to bind to the antibody The degree of binding depends upon their relative concentrations
  • 90. The amount of antibody bound to labeled hormone is quantitated by measuring radio-activity Radio-activity emitted by 125I can be measured by a gamma counter
  • 91. Briefly, the steps are: A series of tubes, marked S1, S2, S3, S4 etc (standards) and U (unknown), is set up A fixed, and relatively small, amount of antibody (Ab) is added to each tube A fixed amount of labeled hormone (Ag*) is added to each tube EMB-RCG
  • 92. Unlabeled hormone (Ag) is added to tubes marked S1, S2, S3 , S4 etc in increasing amounts (C1, C2, C3 , C4 etc) Patient’s serum having an unknown amount of unlabeled hormone (CU) is added to the tube marked U EMB-RCG
  • 93. Amount of antibody (Ab) x x x x x Amount of labeled hormone (Ag*) y y y y y Amount of unlabeled hormone (Ag) C1 C2 C3 C4 ‒ Amount of hormone in patient’s serum – – – – CU S1 S2 S3 S4 U
  • 94. The tubes are incubated for a fixed period Some Ab combines with Ag and some with Ag* EMB-RCG Ag and Ag* compete with each other to bind to the limited amount of Ab
  • 95. The tubes are centrifuged EMB-RCG Ag-Ab and Ag*-Ab complexes settle at the bottom
  • 96. Amounts of Ag-Ab and Ag*-Ab complex in a tube depend upon amounts of Ag* and Ag If the amount of Ag is less than that of Ag*, less Ag-Ab complex will be formed than Ag*-Ab complex As the amount of Ag increases, more Ag-Ab and less Ag*-Ab complex will be formed
  • 97. Ag*-Ab complex is radio-active while Ag-Ab complex is not The concentration of Ag*-Ab complex in different tubes will be different Its concentration will be inversely proportional to the concentration of Ag
  • 98. Ag + Ag* + Ab → Ag-Ab + Ag*-Ab + Ag* + Ag The supernatant containing unbound Ag and Ag* is removed Since antibody concentration is low, some unbound Ag and Ag* will also remain in each tube Radioactivity is measured in each tube
  • 99. A calibration curve is prepared by plotting radioactivity in S1, S2, S3 etc against the concentrations of Ag (C1, C2, C3 etc) The concentration of hormone in the patient’s serum (CU) can be read off from the calibration curve
  • 100. Hormone concentration → C1 C2 Cu C3 C4 ↑ Radio- activity Calibration curve
  • 101. The principle of EIA is similar to that of RIA Instead of an isotope, an enzyme is used as a label The common enzymes used as label are peroxidase and alkaline phosphatase Enzyme-immuno-assay (EIA)
  • 102. Instead of measuring radioactivity, the enzyme concentration is measured For measuring enzyme concentration, substrate of the enzyme is added The amount of product formed is determined after a fixed interval
  • 103. A common form of EIA is enzyme-linked immuno-sorbent assay (ELISA) In ELISA, the antibody is fixed on a solid support The solid support may be wells molded in a plastic plate
  • 104. An ELISA plate with wells molded in it
  • 105. Antibody concentration in the wells is much higher than antigen (hormone) concentration The wells are labeled S1, S2, S3, S4 etc for standard solutions The well labeled U is for unknown i.e. patient’s serum
  • 106. The steps are: Standard hormone solutions in increasing concentrations (C1, C2, C3 etc) are added to the wells marked S1, S2, S3 etc Patient’s serum having an unknown hormone concentration (CU) is added to the well U Hormone molecules bind to the fixed antibody molecules EMB-RCG
  • 107. A second antibody recognizing a different epitope of the antigen (hormone) is tagged with an enzyme It is added to each well in a relatively large amount The enzyme-linked antibody also binds to the hormone EMB-RCG
  • 110. The unbound enzyme-linked antibody molecules are washed off Each well now contains complexes of the fixed antibody, the antigen and the enzyme-linked antibody EMB-RCG
  • 111. A fixed amount of substrate of the enzyme is added to each well The enzyme converts the substrate into a coloured product EMB-RCG
  • 112. Substrate → Product Antibody fixed in well Antigen added; binds to antibody Enzyme-linked antibody added; binds to antigen Substrate added; converted into product   
  • 113. The absorbance is proportional to the enzyme concentration The enzyme concentration is proportional to the hormone concentration EMB-RCG After a fixed incubation period, intensity of colour (absorbance) is measured in each well
  • 114. A calibration curve is plotted between the known concentrations of hormone (C1, C2, C3 etc) and the absorbance The hormone concentration in the patient’s serum (CU) can be read off from the calibration curve EMB-RCG
  • 115. Hormone concentration → C1 C2 C3 C4 CU ↑ Absorbance Calibration curve
  • 116. CLIA is based on chemiluminescence i.e. emission of light driven by a chemical reaction Principle of CLIA is similar to that of EIA Instead of an enzyme, a chemiluminescent substance is used as a label Chemiluminescence-immuno-assay (CLIA)
  • 118. The resulting emission of light is measured The chemiluminescent substance is usually oxidised to form an excited intermediate When this intermediate returns to the ground state, it releases photons
  • 119. Luminol + H2O2 ↓ 3-Aminophthalate + H2O + Light Peroxidase The reaction will occur on addition of H2O2 Luminol can be used as a label
  • 120. Luminol and peroxidase before adding H2O2 Chemiluminescence after addition of H2O2 Chemiluminescence is measured by a luminometer
  • 121. CLIA is extremely sensitive, quick and relatively economical It is linear over a wide range of concentrations of the analyte Shelf-life of CLIA reagents is fairly long